Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF)
Clinical trial NCT05526027 · UNKNOWN
Trial details
- NCT number
- NCT05526027
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-12-31
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.